Legal & General Group
BNR

Legal & General Group’s Burning Rock Biotech BNR Stock Holding History

Legal & General Group’s Portfolio BNR Stock Details BNR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-579
Closed -$14K – 3421
2022
Q3 		$14K Hold
579
– – ﹤0.01% 3282
2022
Q2 		$17K Hold
579
– – ﹤0.01% 3286
2022
Q1 		$54K Hold
579
– – ﹤0.01% 2992
2021
Q4 		$55K Sell
579
-14,646
-96% -$2.01M ﹤0.01% 3014
2021
Q3 		$2.72M Buy
15,225
+171
+1% +$38K ﹤0.01% 1876
2021
Q2 		$4.43M Buy
+15,054
New +$4.45M ﹤0.01% 1599

Other funds holding BNR

KCM
Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Legal & General Group's BNR Position: Q4 2022 in Review

Legal & General Group sold out of Burning Rock Biotech (BNR) in Q4 2022, closing a stake of 579 shares — an estimated $14K sold.

Legal & General Group first reported a position in BNR in Q2 2021 and held it in 6 quarters. The position peaked at $4.43M in Q2 2021. 42 funds tracked by Wall St. Rank hold BNR as of Q4 2022.

  • Legal & General Group reported no remaining Burning Rock Biotech position as of Q4 2022 after selling out during the quarter.
  • Legal & General Group sold 579 Burning Rock Biotech shares in Q4 2022, an estimated $14K.
  • Legal & General Group first reported a position in Burning Rock Biotech in Q2 2021 and held it in 6 quarters.
  • Legal & General Group's Burning Rock Biotech position peaked at $4.43M in Q2 2021.
  • 42 funds tracked by Wall St. Rank held Burning Rock Biotech as of Q4 2022.

Based on Legal & General Group's 13F filing for Q4 2022, filed 14 Feb 2023.